HIF-1α therefore plays complex and potentially opposing roles in mediating tumor survival and the T cell antitumor response, and there are conflicting data as to whether systemic HIF-1α inhibition ultimately enhances or hinders cytotoxic T cell function and tumor growth. The gene discussed is HIF1A; the disease is neoplasm.